PHARMACEUTICAL COMPOSITION CONTAINING BETAMETHASONE VALERATE
The present invention provides a pharmaceutical composition containing betamethasone valerate, which has satisfactory formulation stability. The pharmaceutical composition comprises at least (A) betamethasone valerate and (B) at least one component selected from the group consisting of allantoin, gl...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French Japanese |
Published |
23.09.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides a pharmaceutical composition containing betamethasone valerate, which has satisfactory formulation stability. The pharmaceutical composition comprises at least (A) betamethasone valerate and (B) at least one component selected from the group consisting of allantoin, glycyrrhetinic acid and a salt thereof, and isopropyl methylphenol.
La présente invention concerne une composition pharmaceutique contenant du bétaméthasone valérate, qui présente une stabilité de formulation satisfaisante. La composition pharmaceutique comprend au moins (A) du bétaméthasone valérate et (B) au moins un composant choisi dans le groupe constitué par l'allantoïne, l'acide glycyrrhétinique et un sel de celui-ci, et le méthylphénol d'isopropyle.
本発明は、良好な製剤安定性を有するベタメタゾン吉草酸エステル含有医薬組成物を提供する。当該医薬組成物は、少なくとも(A)ベタメタゾン吉草酸エステルと、(B)アラントイン、グリチルレチン酸及びその塩、並びにイソプロピルメチルフェノールからなる群より選択される少なくとも一種を含有するものである。 |
---|---|
Bibliography: | Application Number: WO2021JP11175 |